Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to SignaBlok in September, 2019 for $799,560.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44CA217400-02 | Phase II | 799,560 | September 25, 2019 | |||||||
A SBIR Phase I contract was awarded to SignaBlok in September, 2020 for $249,601.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AR078110-01 | Phase I | 249,601 | September 10, 2020 | |||||||
A SBIR Phase I contract was awarded to SignaBlok in September, 2020 for $258,603.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AR077456-01A1 | Phase I | 258,603 | September 9, 2020 | |||||||
A SBIR Phase I contract was awarded to SignaBlok in June, 2018 for $226,223.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43EY028779-01A1 | Phase I | 226,223 | June 1, 2018 | |||||||
A SBIR Phase I contract was awarded to SignaBlok in September, 2018 for $224,996.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43GM128369-01A1 | Phase I | 224,996 | September 1, 2018 | |||||||
A SBIR Phase I contract was awarded to SignaBlok in September, 2020 for $220,006.0 USD from the U.S. Department of Defense and Defense Health Agency. | SBIR | W81XWH20P0131 | Phase I | 220,006 | September 24, 2020 | |||||||
A SBIR Phase I contract was awarded to SignaBlok in September, 2016 for $223,443.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AA024355-01A1 | Phase I | 223,443 | September 5, 2016 | |||||||
A SBIR Phase I contract was awarded to SignaBlok in August, 2015 for $219,937.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA195684-01A1 | Phase I | 219,937 | August 18, 2015 | |||||||
A SBIR Phase I contract was awarded to SignaBlok in September, 2017 for $226,756.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA217400-01A1 | Phase I | 226,756 | September 21, 2017 | |||||||
A SBIR Phase II contract was awarded to SignaBlok in July, 2014 for $1,342,812.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HL110417-02 | Phase II | 1,342,812 | July 18, 2014 | |||||||
A SBIR Phase I contract was awarded to SignaBlok for $221,829.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL110417-01A1 | Phase I | 221,829 | ||||||||
A SBIR Phase I contract was awarded to SignaBlok for $221,738.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA167865-01 | Phase I | 221,738 | ||||||||
A SBIR Phase I contract was awarded to SignaBlok for $223,013.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AR066376-01A1 | Phase I | 223,013 | ||||||||
A SBIR Phase I contract was awarded to SignaBlok in August, 2023 for $272,741.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43HL165734-01A1 | Phase I | 272,741 | August 1, 2023 | |||||||
A SBIR Phase I contract was awarded to SignaBlok in September, 2023 for $278,127.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44EY034015-01A1 | Phase I | 278,127 | September 30, 2023 |